Jian You

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

John V. Heymach, David H. Harpole, Tetsuya Mitsudomi et al. · New England Journal of Medicine · 2023 · 682 citations · Full text

Medicine, Oncology, Perioperative Medicine +17

New insight on the correlation of metabolic status on 18F-FDG PET/CT with immune marker expression in patients with non-small cell lung cancer

Yang Wang, Ning Zhao, Zhanbo Wu et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 97 citations

Medicine, Nuclear Medicine, Oncology +17

Abstract CT005: AEGEAN: A phase 3 trial of neoadjuvant durvalumab + chemotherapy followed by adjuvant durvalumab in patients with resectable NSCLC

John V. Heymach, David H. Harpole, Tetsuya Mitsudomi et al. · Cancer Research · 2023 · 84 citations

Medicine, Oncology, Pharmacotherapy +17

The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis

Changli Wang, Yanjun Su, Lianmin Zhang et al. · PLoS ONE · 2012 · 68 citations · Full text

Medicine, Cancer Biology, Oncology +17

Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC)

Zhenzhen Hui, Jiali Zhang, Yulin Ren et al. · Cell Death and Disease · 2022 · 64 citations · Full text

Life Sciences, Immunology, Oncology +17